- $8.62m
- $7.82m
- $4.45m
Brief: Biomerica Reports FDA Submission For Test to Detect H. pylori
Biomerica Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Biomerica Announces Positive Topline Results From Endpoint Clinical Trial Of Its Infoods IBS Treatment
Brief: Biomerica Reports Record Financial Results For Fiscal Second Quarter Ended November 30, 2021
Biomerica Inc reports results for the quarter ended in November - Earnings Summary
Biomerica Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Adobe, Accenture, Under Armour, Novavax
Brief: Biomerica Announces Preliminary Q2 Revenue Increase Of About 238%
Biomerica gains as it sees Q2 revenue more than tripling
Brief: Biomerica Inc SEC Has Concluded Its Previously-Disclosed Investigations With No Enforcement Action Recommendations
Brief: Biomerica Forms Scientific Advisory Board For Colorectal Cancer Screening
Brief: Biomerica Receives Notice Of Allowance From Canadian Patent Office
Brief: Walmart To Begin Nationwide In-Store Sales Of Biomerica’S Ez Detect Colorectal Screening Test
Brief: Biomerica Reports Results For Fiscal First Quarter Ended August 31, 2021
Biomerica Inc expected to post a loss of 12 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Drugmakers, 'Going out' cos, Spire Global
Biomerica soars as Walmart begins selling colorectal disease test
Brief: Walmart Now Selling Biomerica's EZ Detect Colorectal Screening Test
Brief: Biomerica Expects Patient Enrollment Completion For IBS Treatment Trial This Week